首页> 外文期刊>Annals of surgical oncology >Peritoneal Surface Disease (PSD) from Appendiceal Cancer Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Overview of 481 Cases
【24h】

Peritoneal Surface Disease (PSD) from Appendiceal Cancer Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Overview of 481 Cases

机译:细胞减少手术(CRS)和高温腹膜内化学疗法(HIPEC)治疗的阑尾癌腹膜表面疾病(PSD):481例概述

获取原文
获取原文并翻译 | 示例

摘要

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) used to treat peritoneal surface disease (PSD) from appendiceal cancer have shown variability in survival outcomes. The primary goal of this study was to determine predictors of surgical morbidity and overall survival. The secondary goal was to describe the impact of nodal status on survival after CRS/HIPEC for PSD from low-grade appendiceal (LGA) and high-grade appendiceal (HGA) primary lesions.
机译:用于治疗阑尾癌腹膜表面疾病(PSD)的细胞减灭术(CRS)和腹膜内高温化疗(HIPEC)已显示出生存结果的差异。这项研究的主要目的是确定手术发病率和总生存率的预测指标。次要目标是描述从低度阑尾(LGA)和高度阑尾(HGA)原发病变的PSD对CRS / HIPEC后,结节状态对存活的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号